October 22 coronavirus news

By Joshua Berlinger, Adam Renton, Tara John and Ed Upright, CNN

Updated 12:00 a.m. ET, October 23, 2020
15 Posts
Sort byDropdown arrow
3:34 a.m. ET, October 22, 2020

Germany reports fresh single-day high in new Covid-19 cases

From CNN’s Samantha Beech

A medical worker takes a nasal swab at a coronavirus testing center in Cologne, Germany, on October 15.
A medical worker takes a nasal swab at a coronavirus testing center in Cologne, Germany, on October 15. Martin Meissner/AP

Germany identified a new high of 11,287 cases of Covid-19 in a single day, the country's center for disease control, the Robert Koch Institute (RKI), reported Thursday. Another 30 people died from the virus.

More than 392,000 coronavirus cases have been diagnosed in Germany since the pandemic began, killing 9,905 people, according to the RKI.

Germany is one of several countries throughout Europe battling a new wave of Covid-19 cases.

2:56 a.m. ET, October 22, 2020

Brazilian senator dies of Covid-19

From CNN's Flora Charner in Atlanta

Brazilian Senator Arolde de Oliveira died Wednesday from complications related to Covid-19, according to a statement published on his official Twitter account. He was 83. 

Oliveira died from multiple organ failure caused by Covid-19, the statement said. He had been hospitalized for more than 15 days in Rio de Janeiro, according to CNN affiliate CNN Brasil. 

Oliveira is the first member of the Brazilian Congress to die from coronavirus.   

  

Oliveira, a conservative senator from Rio de Janeiro state with close ties to President Jair Bolsonaro, served in Congress for more than 35 years. He was in his first term in the Senate after being elected in 2018. He had previously served nine consecutive terms in the lower house of Congress.  

The state of Rio de Janeiro declared three days of mourning in honor of Oliveira, according to a statement from the governor’s office.    

2:11 a.m. ET, October 22, 2020

Rheumatoid arthritis drug falls short as treatment for hospitalized Covid-19 patients in three studies

From CNN's Andrea Kane

Tocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with Covid-19, generally did not increase patients' chances of survival or help them get better faster, according to three trials published this week.

However, a fourth trial did find the drug increased the chances of survival, but because it was an observational study, the results are considered less definitive.

Three of the trials were published Tuesday in the Journal of the American Medical Association and the other was published Wednesday in the New England Journal of Medicine.

While this leaves the picture for tocilizumab use a bit muddy, the studies taken together show the drug isn't a magic bullet that should be used in all hospitalized patients with Covid-19, but they leave the door open for possible use in specific patient groups.

"It is possible that forthcoming results from other randomized trials will help us identify specific groups of people who will benefit. However, growing evidence supports current guidelines, which recommend against tocilizumab use outside of clinical trials," Dr. Jonathan Parr told CNN.

Read the full story:

1:43 a.m. ET, October 22, 2020

Only 6,000 participants have so far received both doses in Russian vaccine's Phase 3 trial

From CNN’s Fred Pleitgen and Mary Ilyushina in Moscow

Only 6,000 participants have so far received both doses of the Russian vaccine for Covid-19 that are necessary to complete the vaccination, the drug's developers said.

To date, 17,000 people have received the first component of the Sputnik V vaccine, Alexander Gintsburg, director of the Gamaleya Institute that created the vaccine, told CNN in an exclusive interview Wednesday.  

"No side effects other than those listed in the instructions and that are characteristic of any vaccine included in the national vaccination protocols have been registered as of now," Gintsburg said. 

By comparison, as of October 6, the vaccine cooperation of Germany's BioNTech and US drugmaker Pfizer reported to have enrolled approximately 37,000 participants in the Phase 3 trial for their vaccine candidate. More than 28,000 participants in that trial have received their second dose.

Russia approved the Sputnik V vaccine for emergency use ahead of key Phase 3 trials. Moscow claimed it was the first certified coronavirus vaccine, despite only having been tested on several dozen people,

So far, about 40,000 doses of Sputnik V have been supplied to the general population under emergency use authorization decree -- mostly doctors, Covid-19 patients and teachers, Gintsburg said. 

Gintsburg said that his institute and the Russian Direct Investment Fund, which sponsored the vaccine, plan to scale up production of Sputnik V in the next month using private sector sites, with the goal of producing 5 million vaccines a month by next year.

“(Such rate) will allow 70% of our population to be vaccinated with this vaccine within nine, 10 to a maximum of 12 months, which is enough to make this disease controlled by the vaccine,” Gintsburg said.
1:25 a.m. ET, October 22, 2020

More than 62,000 coronavirus cases were reported in the US on Wednesday

From CNN's Joe Sutton

The United States reported 62,735 new cases of Covid-19 and 1,124 virus-related deaths on Wednesday, according to Johns Hopkins University's tally of cases.

To date, at least 8,336,031 cases of coronavirus have been diagnosed in the US. At least 222,176 people have died.

The totals include cases from all 50 states, the District of Columbia and other US territories, as well as repatriated cases. 

Track cases here:

9:50 a.m. ET, October 22, 2020

Always tell truth to power, Fauci says, even if it could cost you your job

From CNN Health’s Shelby Lin Erdman

Dr. Anthony Fauci testifies before a House Subcommittee on the Coronavirus Crisis hearing on July 31 in Washington. 
Dr. Anthony Fauci testifies before a House Subcommittee on the Coronavirus Crisis hearing on July 31 in Washington.  Kevin Dietsch-Pool/Getty Images

Dr. Anthony Facui, the United States' leading expert on infectious diseases, advised people during a recent interview that they should "always tell the truth," even if it’s something others don’t want to hear or it could cost you your job.

In a conversation posted online Wednesday, Fauci told the Council of Inspectors General on Integrity and Efficiency that "if in fact, somebody does want to shoot the messenger and say ‘I don't like what they're saying, I don't want to talk to them any more,’ so be it."

“At least you maintain your integrity," said Fauci, who heads the National Institute of Allergy and Infectious Diseases. Fauci also is a member of the White House's coronavirus task force.

The comments come as Fauci has found himself on the receiving end of public and private criticism by US President Donald Trump.

"People are tired of Covid. I have the biggest rallies I've ever had, and we have Covid," Trump said while phoning into a call with campaign staff from his namesake hotel in Las Vegas, where he spent two nights amid a western campaign swing. "People are saying whatever. Just leave us alone. They're tired of it. People are tired of hearing Fauci and all these idiots."

Fauci never mentioned Trump by name and used himself as a leading scientist as an example of how he views leadership, but his comments follow Trump’s recent derogatory remarks about him.

“The one thing that is so clear when you're, you’re a leader, you've got to first of all be very consistent,” Fauci said in response to a question about his leadership and past role models.

12:50 a.m. ET, October 22, 2020

Manchester United reports more than $30 million in losses due to Covid-19

From CNN's Aleks Klosok and Rob North in London

The corner flag inside the stadium prior to the Premier League match between Manchester United and Norwich City at Old Trafford on January 11, in Manchester, United Kingdom.
The corner flag inside the stadium prior to the Premier League match between Manchester United and Norwich City at Old Trafford on January 11, in Manchester, United Kingdom. Catherine Ivill/Getty Images

Manchester United, one of the world's most iconic and valuable sports teams, reported financial losses of $30.3 million this year, a slump largely attributed to the global pandemic.

The English Premier League soccer club said its finances were severely impacted by a loss of broadcasting income. The league enacted a three-month suspension of play from March until June as the first wave of the pandemic took hold. Premier League stadiums have been closed to fans since mid-March as a result of the pandemic.

The club was valued at $3.81 billion in July by Forbes, making it the world's 10th most valuable sports team.

Revenue as a whole dropped by $664 million -- down almost 19% on the previous year -- but the losses were partially offset by lower match-day costs and reduced travel, among other things.

Debt at the club has also grown to $618 million – an increase of 132.9% on the previous year in the club’s latest round of financial results.  

"Our top priority is to get fans back into the stadium safely and as soon as possible," executive vice chairman Ed Woodward said in a statement.
12:21 a.m. ET, October 22, 2020

More than 5,600 people were diagnosed with Covid-19 in Iran in a 24-hour period

From Ramin Mostaghim in Tehran

Iran’s Health Ministry said Wednesday that 5,616 new Covid-19 cases were diagnosed over a 24 hour-period -- a new daily high for the second consecutive day in the country.

Another 312 coronavirus-related deaths were reported, bringing the nationwide total to 31,346, Health Ministry spokeswoman Sima Sadat Lari said Wednesday on state television.

Wearing masks in public is mandatory in the capital Tehran and a restriction on travel in and out of Tehran province is in place until at least Friday. 

12:03 a.m. ET, October 22, 2020

Coronavirus vaccine volunteer in Brazil's AstraZeneca trial dies -- but authorities say trial to continue

From CNN's Jo Shelley and Jacqueline Howard

A volunteer in Brazil's trial of AstraZeneca's experimental coronavirus vaccine has died, the Brazilian health agency Anvisa announced on Wednesday, but organizers said there was no reason to stop the trial -- an indication that the death is not linked to the vaccine.

Anvisa said that it was notified of the death on Monday but the International Evaluation and Security Committee overseeing the trial recommended that the trial continue. It was not clear whether the volunteer received the vaccine or a placebo shot as part of the trial, and Anvisa said no more information was being released for reasons of medical privacy.

Read more: